iDropper Usability in Glaucoma

Withdrawn before enrolling · Phase 1

Conditions studied: Glaucoma, Open-Angle [C11.525.381.407]

In brief

The purpose of this study is to evaluate the usability of a medication management support system for glaucoma patients self-administering eye drops named iDropper. The iDropper system is a home-based ocular medication management system that reminds, instructs, dispenses, and records eye drop medication usage. The iDropper system will be evaluated among a cohort of glaucoma subjects self-administering eye drops for 4-weeks.

Key facts

Study ID

NCT02031380

Run by

Care Team Solutions

People needed

0

Starts

2014-04-01

Expected to finish

2014-12-01

Last updated by the study team

2015-12-08

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 21 years of age;
• Physician diagnosis of: open angle glaucoma, angle-closure glaucoma, glaucoma suspect, or ocular hypertension
• Responsible for self-administration of eye drops.
• No surgery within the prior 3 months;
• Able to speak and read English;

You may not qualify if…

• Having any concurrent medical or psychiatric condition that, in the investigator's opinion, may preclude participation in this study; or
• Cognitive or visual impairment that would interfere with completing a self-administered questionnaire.

Where it is running

• University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.